NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Crossject Société Anonyme (PA: ALCJ)
ALCJ Technical Analysis
5
As on 2nd Apr 2025 ALCJ STOCK Price closed @ 1.16 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.09 & Strong Sell for SHORT-TERM with Stoploss of 4.49 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ALCJSTOCK Price
Open | 1.13 | Change | Price | % |
High | 1.24 | 1 Day | 0.08 | 7.41 |
Low | 1.11 | 1 Week | -0.60 | -34.09 |
Close | 1.16 | 1 Month | -0.63 | -35.20 |
Volume | 518610 | 1 Year | -2.69 | -69.87 |
52 Week High 5.83 | 52 Week Low 1.31 |
PA France Most Active Stocks
ATO | 0.00 | % |
ALALO | 0.00 | % |
ALVER | 0.00 | % |
ALEUP | 0.02 | 100.00% |
FTI | 5.91 | -1.66% |
VIEDS | 0.72 | 4.35% |
ORA | 11.99 | -0.83% |
ENGI | 18.43 | 1.43% |
CGG | 0.69 | -2.82% |
ALNRG | 0.01 | % |
PA France Top Gainers Stocks
PA France Top Losers Stocks
ALCJ Daily Charts |
ALCJ Intraday Charts |
Whats New @ Bazaartrend |
ALCJ Free Analysis |
|
ALCJ Important Levels Intraday
RESISTANCE | 1.41 |
RESISTANCE | 1.33 |
RESISTANCE | 1.28 |
RESISTANCE | 1.23 |
SUPPORT | 1.09 |
SUPPORT | 1.04 |
SUPPORT | 0.99 |
SUPPORT | 0.91 |
ALCJ Forecast April 2025
4th UP Forecast | 2.95 |
3rd UP Forecast | 2.38 |
2nd UP Forecast | 2.02 |
1st UP Forecast | 1.67 |
1st DOWN Forecast | 0.65 |
2nd DOWN Forecast | 0.3 |
3rd DOWN Forecast | -0.06 |
4th DOWN Forecast | -0.63 |
ALCJ Weekly Forecast
4th UP Forecast | 2.24 |
3rd UP Forecast | 1.89 |
2nd UP Forecast | 1.68 |
1st UP Forecast | 1.47 |
1st DOWN Forecast | 0.85 |
2nd DOWN Forecast | 0.64 |
3rd DOWN Forecast | 0.43 |
4th DOWN Forecast | 0.08 |
ALCJ Forecast2025
4th UP Forecast | 10.6 |
3rd UP Forecast | 7.57 |
2nd UP Forecast | 5.7 |
1st UP Forecast | 3.83 |
1st DOWN Forecast | -1.51 |
2nd DOWN Forecast | -3.38 |
3rd DOWN Forecast | -5.25 |
4th DOWN Forecast | -8.28 |
Crossject Société Anonyme ( PA France Symbol : ALCJ )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ALCJ Other Details
Segment | EQ | |
Market Capital | 76467520.00 | |
Sector | Healthcare | |
Industry | Medical Instruments & Supplies | |
Offical website | > echo $website ; ?> |
ALCJ Address
![]() |
ALCJ Latest News
ALCJ Business Profile
Crossject Société Anonyme develops needle-free injection systems. The company develops ZENEO, a needle-free, prefilled, and single-use auto-injector. Its clinical stage drugs comprise Sumatriptan, which is used for of treatment migraines and cluster headaches; Adrenaline for treating anaphylactic shock; Hydrocortisone that is used for treatment of acute adrenal crisis; Midazolam for treating epileptic seizure; Naloxone used for treatment of overdose; Apomorphine, for treating temporary paralysis in parkinson's disease; Methotrexate used for treatment of rheumatoid arthritis; and Terbutaline, for treating severe asthma crisis. The company was founded in 1997 and is based in Dijon, France. Address: 6 Rue Pauline Kergomard, Dijon, France, 21000
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service